MEDADVISOR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.33 AUD | 0.00% |
|
+4.76% | +53.49% |
| 04-24 | MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter | MT |
| 04-23 | MedAdvisor's Gross Profit Climbs 48.5% in Fiscal Q3, Revenue Rises 42.4% | MT |
Evolution of the average Target Price on MedAdvisor Limited
Price target over the last 5 years
History of analyst recommendation changes
c460ec879e53895ffa5500d7.F4E1RZMsaVPddUtauy2TdrUpanCo7VdkqpKtAKpUDaM.JOBwB8wdWhmpNhkd5GzpI_BgLjbqnT8DzdP7VcYTZ-xT5QZy6WY4JLkDIA~a2a4864664f61b8e46f876a584e12707
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.33
AUD
Average target price
0.4233
AUD
Spread / Average Target
+28.28%
High Price Target
0.47
AUD
Spread / Highest target
+42.42%
Low Price Target
0.39
AUD
Spread / Lowest Target
+18.18%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- MDR Stock
- Consensus MedAdvisor Limited